<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:openSearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:georss="http://www.georss.org/georss" xmlns:creativeCommons="http://backend.userland.com/creativeCommonsRssModule" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0"><channel><atom:id>tag:blogger.com,1999:blog-1542637279186075353</atom:id><lastBuildDate>Fri, 10 Jul 2009 18:41:13 +0000</lastBuildDate><title>Partnerships With CROs</title><description>This blog presents best practices on forming, managing and sustaining successful clinical outsourcing partnerships.</description><link>http://partnershipswithcros.blogspot.com/</link><managingEditor>noreply@blogger.com (Yemil)</managingEditor><generator>Blogger</generator><openSearch:totalResults>212</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><creativeCommons:license>http://creativecommons.org/licenses/by/2.0/</creativeCommons:license><image><link>http://creativecommons.org/licenses/by/2.0/</link><url>http://creativecommons.org/images/public/somerights20.gif</url><title>Some Rights Reserved</title></image><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.feedburner.com/PartnershipsWithCros" type="application/rss+xml" /><feedburner:emailServiceId>PartnershipsWithCros</feedburner:emailServiceId><feedburner:feedburnerHostname>http://feedburner.google.com</feedburner:feedburnerHostname><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com" /><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-8555209938364954334</guid><pubDate>Fri, 10 Jul 2009 15:34:00 +0000</pubDate><atom:updated>2009-07-10T14:41:13.316-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Outsourcing Clinical Trials</category><category domain="http://www.blogger.com/atom/ns#">Amgen</category><category domain="http://www.blogger.com/atom/ns#">CROs</category><category domain="http://www.blogger.com/atom/ns#">Pfizer</category><category domain="http://www.blogger.com/atom/ns#">United Arab Emirates</category><category domain="http://www.blogger.com/atom/ns#">Astrazeneca</category><category domain="http://www.blogger.com/atom/ns#">Partnerships with CROs</category><title>United Arab Emirates is Set to Rise in Clinical Trials</title><atom:summary>According to this post in outsourcing-pharma.com the United Arab Emirates is set to grow in the CRO industry due to the attractive of cost effectiveness there.  Kermani, author of A quick guide to healthcare and biotechnology in the Middle East, predicts that with big pharma companies like Pfizer, Amgen and AstraZeneca establishing  offices in UAE, many more CROs will follow.What are some other </atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/-KQefnzocio/united-arab-emirates-is-set-to-rise-in.html</link><author>noreply@blogger.com (Thiago)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/-KQefnzocio" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/07/united-arab-emirates-is-set-to-rise-in.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-2631058960743544242</guid><pubDate>Thu, 09 Jul 2009 15:35:00 +0000</pubDate><atom:updated>2009-07-09T11:45:43.588-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">life science leader</category><category domain="http://www.blogger.com/atom/ns#">insourcing</category><category domain="http://www.blogger.com/atom/ns#">Changing Face of CROs</category><category domain="http://www.blogger.com/atom/ns#">stephanie wells</category><category domain="http://www.blogger.com/atom/ns#">CROs news</category><category domain="http://www.blogger.com/atom/ns#">Partnerships with CROs</category><title>Insourcing Is The New Outsourcing In Biopharma</title><atom:summary>Stephanie Wells of Life Science Leader writes, The growth of insourcing means that the future of contracted work is likely to be a blended approach. In some cases, the CRO would provide traditional external services, like general toxicology studies or Phase II clinical studies. In other cases, when a client is working in a new area and has not yet developed the necessary infrastructure, </atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/p0VIVxQxRU0/insourcing-is-new-outsourcing-in.html</link><author>noreply@blogger.com (Melissa)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/p0VIVxQxRU0" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/07/insourcing-is-new-outsourcing-in.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-6034231549485034336</guid><pubDate>Wed, 08 Jul 2009 14:12:00 +0000</pubDate><atom:updated>2009-07-08T10:16:44.871-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">CT Comply</category><category domain="http://www.blogger.com/atom/ns#">Clinical trails compliance</category><category domain="http://www.blogger.com/atom/ns#">CT professionals</category><category domain="http://www.blogger.com/atom/ns#">Clinical Research Outsourcing</category><category domain="http://www.blogger.com/atom/ns#">Thompson Publishing</category><category domain="http://www.blogger.com/atom/ns#">Online database</category><category domain="http://www.blogger.com/atom/ns#">Partnerships with CROs</category><title>New online tool to help with compliance</title><atom:summary>Thompson Publishing has released a new online tool that will allow clinical trail conductors to keep up to date with key compliance issues and continue with their operations.  CT Comply is a powerful database that provides up-to-the-minute news, analysis and research tools in one place online.J.W. Schomisch, senior managing editor at Thompson, and editor of the widely acclaimed Guide to Good </atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/RnejAzWdnko/new-online-tool-to-help-with-compliance.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/RnejAzWdnko" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/07/new-online-tool-to-help-with-compliance.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-7759131172341348347</guid><pubDate>Mon, 06 Jul 2009 15:50:00 +0000</pubDate><atom:updated>2009-07-06T14:36:19.288-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">sparta systems</category><category domain="http://www.blogger.com/atom/ns#">trackwise clinical quality management solution</category><category domain="http://www.blogger.com/atom/ns#">CROs news</category><title>Software offers holistic insight into clinical trials.</title><atom:summary>Thomasnet.com reports that TrackWise Clinical Quality Management Solution provides end-to-end system that streamlines oversight of business-critical clinical trial processes while helping to ensure compliance with global regulatory standards. Driving organizational efficiencies from pre-clinical activities through manufacturing and post-market operations, solution delivers closed-loop process </atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/gkGkvR2ZMnU/software-offers-holistic-insight-into.html</link><author>noreply@blogger.com (Melissa)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/gkGkvR2ZMnU" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/07/software-offers-holistic-insight-into.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-6591971398476017183</guid><pubDate>Thu, 02 Jul 2009 14:43:00 +0000</pubDate><atom:updated>2009-07-02T10:48:09.955-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Africa clinical trials</category><category domain="http://www.blogger.com/atom/ns#">Clinical research</category><category domain="http://www.blogger.com/atom/ns#">adderssing health issues</category><category domain="http://www.blogger.com/atom/ns#">Partnerships with CROs</category><title>How to find the best cost-effective treatments</title><atom:summary>According to Red Orbit, Congress has allotted $1.1 billion to begin finding the best treatments for certain ailments that are also cost-effective. A report came out addressing the top 100 medical issues addressed by Congress. The report said this of clinical trials:“Clinical research provides health care providers with information on the natural history of disease, clinical presentations of </atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/GRqJeaFl0ds/how-to-find-best-cost-effective.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/GRqJeaFl0ds" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/07/how-to-find-best-cost-effective.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-3949046642750951518</guid><pubDate>Wed, 01 Jul 2009 19:38:00 +0000</pubDate><atom:updated>2009-07-01T15:47:15.037-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">chinese cros</category><category domain="http://www.blogger.com/atom/ns#">contract research organizations</category><category domain="http://www.blogger.com/atom/ns#">CROs news</category><category domain="http://www.blogger.com/atom/ns#">Partnerships with CROs</category><category domain="http://www.blogger.com/atom/ns#">customs clearance</category><title>Chinese CROs trial express customs clearance</title><atom:summary>PharmaTimes reports that, three contract research organizations (CROs) operating out of China’s Zhangjiang Hi-Tech Park are trying out a new express customs clearance model that could eventually be extended to other CROs in the Park. Its been well-known that customs clearance for CROs has been a difficult process for many CROs, with the new customs clearance model high import/export volume and </atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/dNVcLM6wsiw/chinese-cros-trial-express-customs.html</link><author>noreply@blogger.com (Melissa)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">1</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/dNVcLM6wsiw" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/07/chinese-cros-trial-express-customs.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-6102431332117713887</guid><pubDate>Mon, 29 Jun 2009 17:17:00 +0000</pubDate><atom:updated>2009-06-29T13:22:17.407-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">San Francisco</category><category domain="http://www.blogger.com/atom/ns#">Clinical trials</category><category domain="http://www.blogger.com/atom/ns#">Biotech</category><category domain="http://www.blogger.com/atom/ns#">CROs</category><category domain="http://www.blogger.com/atom/ns#">Biotech innovation</category><category domain="http://www.blogger.com/atom/ns#">Biofuel production</category><category domain="http://www.blogger.com/atom/ns#">Blockbuster drugs</category><category domain="http://www.blogger.com/atom/ns#">Partnerships with CROs</category><category domain="http://www.blogger.com/atom/ns#">Diagnostics testing</category><category domain="http://www.blogger.com/atom/ns#">Innovation</category><title>Innovation needed for biotechs</title><atom:summary>An article in the San Francisco Chronicle believes that Biotech is in need of innovation, and points to diagnostics testing and biofuel production as the next possible chance, as it takes many many years to develop blockbuster drugs.  Innovation was possible before because of the fact that investors were willing to risk time and money to come up with the next blockbuster drug.  Innovation is </atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/YWCium-F8sQ/innovation-needed-for-biotechs.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/YWCium-F8sQ" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/06/innovation-needed-for-biotechs.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-6435404703694110355</guid><pubDate>Wed, 24 Jun 2009 20:40:00 +0000</pubDate><atom:updated>2009-06-24T16:45:14.671-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">The Medical News</category><category domain="http://www.blogger.com/atom/ns#">Clinical trials</category><category domain="http://www.blogger.com/atom/ns#">Austrailia</category><category domain="http://www.blogger.com/atom/ns#">Insulin</category><category domain="http://www.blogger.com/atom/ns#">Clinical trial</category><category domain="http://www.blogger.com/atom/ns#">Diabetes</category><category domain="http://www.blogger.com/atom/ns#">Diabecell</category><category domain="http://www.blogger.com/atom/ns#">Partnerships with CROs</category><title>Clinical trial shows hope for no more insulin injections</title><atom:summary>According to The Medical News, an Australian clinical trial will commence for the treatment of type I diabetes  that will not require daily insulin injections.  The trial will now move on to Auckland, New Zealand in Middlemore Hospital.Prof. Bob Elliott, Founder of LCT and diabetes specialist,  said: "We have great hopes for these trials. We already have two patients in the Russian trials that </atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/qrw17FCt4t0/clinical-trial-shows-hope-for-no-more.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/qrw17FCt4t0" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/06/clinical-trial-shows-hope-for-no-more.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-665910156716493469</guid><pubDate>Thu, 18 Jun 2009 20:58:00 +0000</pubDate><atom:updated>2009-06-18T17:00:50.841-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Clinical trial software</category><category domain="http://www.blogger.com/atom/ns#">TransSenda</category><category domain="http://www.blogger.com/atom/ns#">Clinical trials</category><category domain="http://www.blogger.com/atom/ns#">Cortex</category><category domain="http://www.blogger.com/atom/ns#">CROs partners</category><category domain="http://www.blogger.com/atom/ns#">Clinical trial efficiency</category><category domain="http://www.blogger.com/atom/ns#">Partnerships with CROs</category><title>New software for clinical trials</title><atom:summary>TranSenda has a new software that will help the efficiency of all clinical trails.  It'll improve the ability to manage the clinical study.Cortex will enable organizations to leverage the power of        access to centralized operational data from all applications used across        all clinical studies.Read more about the software here.</atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/P_VYTqYODXo/new-software-for-clinical-trials.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/P_VYTqYODXo" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/06/new-software-for-clinical-trials.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-4573201543406910479</guid><pubDate>Tue, 16 Jun 2009 14:07:00 +0000</pubDate><atom:updated>2009-06-16T10:14:13.883-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">FiercePharma</category><category domain="http://www.blogger.com/atom/ns#">Phase I</category><category domain="http://www.blogger.com/atom/ns#">Community awareness</category><category domain="http://www.blogger.com/atom/ns#">Patient recruitment</category><category domain="http://www.blogger.com/atom/ns#">Media outlets</category><category domain="http://www.blogger.com/atom/ns#">Partnerships with CROs</category><category domain="http://www.blogger.com/atom/ns#">Clinical trials patient recruitment</category><title>Finding patients in Phase I clinical trials</title><atom:summary>At FiercePharma, they  look at how to effectively recruit patients in a CRO's local area for Phase I clinical trials.  They suggest joining your local community to spread awareness and developing new media outlets to spread the word but not over saturate the market.  For more, read the article here.</atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/s-j_5ojbMds/finding-patients-in-phase-i-clinical.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/s-j_5ojbMds" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/06/finding-patients-in-phase-i-clinical.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-3631546623852660868</guid><pubDate>Mon, 15 Jun 2009 15:37:00 +0000</pubDate><atom:updated>2009-06-15T11:41:48.142-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Genomeweb</category><category domain="http://www.blogger.com/atom/ns#">CROs</category><category domain="http://www.blogger.com/atom/ns#">Sigma Alpha</category><category domain="http://www.blogger.com/atom/ns#">Changing Face of CROs</category><category domain="http://www.blogger.com/atom/ns#">Tony Fong</category><title>Sigma-Alpha Moves Differently from Classic CROs Offerings</title><atom:summary>Last week, Tony Fong of Genomeweb reported that, Sigma-Aldrich, hoping to grab a bigger slice of the biopharma industry's expanding appetite for outsourcing, (last) week expanded its services business to include mass spectrometry-based protein characterization, protein expression, and protein purification.The idea is not for Sigma-Aldrich to collaborate with biopharmas on large-scale projects and</atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/KQtM1DuUAJQ/sigma-alpha-moves-differently-from.html</link><author>noreply@blogger.com (Melissa)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/KQtM1DuUAJQ" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/06/sigma-alpha-moves-differently-from.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-2948735547028873350</guid><pubDate>Fri, 12 Jun 2009 13:57:00 +0000</pubDate><atom:updated>2009-06-12T09:58:03.629-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Meetings Drive Business</category><category domain="http://www.blogger.com/atom/ns#">Partnerships with CROs</category><title>Meetings Drive Business</title><atom:summary>This is why companies need to continue to invest in business meetings. Not only will those who attend gain new and fresh perspectives from other attendees, but they'll hear from top companies who have lived by the same philosophy. Investment in yourself and innovation are the key to your business. What have you done recently to invest in your business?Did you get a chance to attend Partnerships </atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/a5OBdAjXAV8/meetings-drive-business.html</link><author>noreply@blogger.com (Thiago)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/a5OBdAjXAV8" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/06/meetings-drive-business.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-3728467200169648378</guid><pubDate>Fri, 12 Jun 2009 13:41:00 +0000</pubDate><atom:updated>2009-06-12T09:45:23.936-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">New York Times</category><category domain="http://www.blogger.com/atom/ns#">Schering Plough</category><category domain="http://www.blogger.com/atom/ns#">Merck</category><category domain="http://www.blogger.com/atom/ns#">Pfizer</category><category domain="http://www.blogger.com/atom/ns#">CRO partners</category><category domain="http://www.blogger.com/atom/ns#">Pharma mergers</category><category domain="http://www.blogger.com/atom/ns#">Clinical Research Outsourcing</category><category domain="http://www.blogger.com/atom/ns#">Partnerships with CROs</category><title>Merck to cut jobs</title><atom:summary>According to the New York Times, the Merck merger with Schering-Plough will eliminate 16,000 jobs from the company.  After the merger, the group will be the second largest Pharma company.  Pfizer will remain the largest.  Read the full story here.</atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/fflaychAy54/merck-to-cut-jobs.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/fflaychAy54" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/06/merck-to-cut-jobs.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-1583558695721234681</guid><pubDate>Thu, 11 Jun 2009 16:01:00 +0000</pubDate><atom:updated>2009-06-11T12:09:08.540-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Clinical trials</category><category domain="http://www.blogger.com/atom/ns#">Clinical trial payments</category><category domain="http://www.blogger.com/atom/ns#">Electronic payments</category><category domain="http://www.blogger.com/atom/ns#">Underbanked</category><category domain="http://www.blogger.com/atom/ns#">Greenphire</category><category domain="http://www.blogger.com/atom/ns#">Partnerships with CROs</category><category domain="http://www.blogger.com/atom/ns#">ClinPage</category><title>How do you pay the participants in your clinical trials?</title><atom:summary>In an article at ClinPage recently, they look at how Greenphire is speeding up the process of paying those involved in the clinical trial process.  They believe that by making payments available through prepaid cards which are also electronic payments, a lot of confusion can be saved as well as those trial participants involved who are underbanked have a way to receive payments.  Read the full </atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/CeHbIegkKZw/how-do-you-pay-participants-in-your.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/CeHbIegkKZw" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/06/how-do-you-pay-participants-in-your.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-5389067548425695054</guid><pubDate>Mon, 08 Jun 2009 19:48:00 +0000</pubDate><atom:updated>2009-06-08T15:51:35.091-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Women trial participants</category><category domain="http://www.blogger.com/atom/ns#">Gender differences to medicine</category><category domain="http://www.blogger.com/atom/ns#">Women in clinical trials</category><category domain="http://www.blogger.com/atom/ns#">Cancer research</category><category domain="http://www.blogger.com/atom/ns#">Atlanta Journal Constitution</category><title>Women in cancer clinical trials</title><atom:summary>According to a news article at the Atlanta Journal Constitution, clinical trials dealing with cancer research aren't including enough women.  Doctors may not be able to identify all of the gender differences that occur between women and men, as only 37% of trial participants are women.  Read the full article here.</atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/uhtHtqQQKPY/women-in-cancer-clinical-trials.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/uhtHtqQQKPY" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/06/women-in-cancer-clinical-trials.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-887530179024331669</guid><pubDate>Fri, 05 Jun 2009 15:49:00 +0000</pubDate><atom:updated>2009-06-05T11:51:16.492-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">IIR</category><category domain="http://www.blogger.com/atom/ns#">Changing Face of CROs</category><category domain="http://www.blogger.com/atom/ns#">CROs news</category><category domain="http://www.blogger.com/atom/ns#">Partnerships with CROs</category><category domain="http://www.blogger.com/atom/ns#">CROs orlando</category><title>CROs 2009 Workshop Video</title><atom:summary>For those who missed the workshop last month in Orlando, we are providing unlimited access to this timely workshop to all Partnerships attendees and their colleagues. And since we understand your training and travel budgets are limited at this time, this video workshop is completely free of charge.Simply click the link below to watch the video at your leisure, and feel free to pass along to your </atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/-JB43ltyVp0/cros-2009-workshop-video.html</link><author>noreply@blogger.com (Melissa)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/-JB43ltyVp0" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/06/cros-2009-workshop-video.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-1375604903037340100</guid><pubDate>Wed, 03 Jun 2009 15:14:00 +0000</pubDate><atom:updated>2009-06-03T11:22:20.264-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Risks of outsourcing</category><category domain="http://www.blogger.com/atom/ns#">Ontario</category><category domain="http://www.blogger.com/atom/ns#">China clinical trials</category><category domain="http://www.blogger.com/atom/ns#">National Post</category><category domain="http://www.blogger.com/atom/ns#">Argentina clinical trials</category><category domain="http://www.blogger.com/atom/ns#">Culture standards</category><category domain="http://www.blogger.com/atom/ns#">Clinical Research Outsourcing</category><category domain="http://www.blogger.com/atom/ns#">India clinical research</category><category domain="http://www.blogger.com/atom/ns#">Partnerships with CROs</category><title>Outsourcing challenges</title><atom:summary>In a recent article at the National Post of Ontario, Canada, they look at the some of the risks that are associated with outsourcing clinical trials to other countries.  A few of the roadbumps could be: different culture with different standards, the application quality between the two different populations, and the treatment of patients.  There have been a surge of clinical trials being </atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/xyAkjQj9ilw/outsourcing-challenges.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/xyAkjQj9ilw" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/06/outsourcing-challenges.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-8691633324347488185</guid><pubDate>Mon, 01 Jun 2009 14:59:00 +0000</pubDate><atom:updated>2009-06-01T11:02:58.216-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">whitepapers</category><category domain="http://www.blogger.com/atom/ns#">CRO free reports</category><category domain="http://www.blogger.com/atom/ns#">Partnerships with CROs</category><category domain="http://www.blogger.com/atom/ns#">novotech</category><category domain="http://www.blogger.com/atom/ns#">indian cros</category><title>Novotech in Joint Venture with Indian CRO, Focuses on Asian Expansion</title><atom:summary>We invite you to download this complimentary report, "Novotech in Joint Venture with Indian CRO, Focuses on Asian Expansion."Please feel free to add any comments to this post or continue the discussion on Twitter.http://www.iirusa.com/upload/wysiwyg/New%20Media/cww1320_May18.pdf?utm_source=CROs%2BWebpage&amp;utm_medium=Link&amp;utm_term=CROs&amp;utm_content=Novotech%2Bin%20Joint%20Venture%20with%20Indian%</atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/sANlHwsP-50/novotech-in-joint-venture-with-indian.html</link><author>noreply@blogger.com (Melissa)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/sANlHwsP-50" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/06/novotech-in-joint-venture-with-indian.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-1701315973759728912</guid><pubDate>Thu, 28 May 2009 14:10:00 +0000</pubDate><atom:updated>2009-05-28T12:36:51.421-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">BD execs</category><category domain="http://www.blogger.com/atom/ns#">Changing Face of CROs</category><category domain="http://www.blogger.com/atom/ns#">CROs news</category><category domain="http://www.blogger.com/atom/ns#">business development professionals</category><category domain="http://www.blogger.com/atom/ns#">partnerships with cros panel</category><title>As Sponsors increasingly look to CROs to provide expertise, what level of experience do CRO project managers need going forward?</title><atom:summary>Partnerships with CROs is providing unlimited, complimentary access to the video of our highly rated premier workshop for CRO Business Development professionals, CRO Strategies for Adapting to the Changing Tides in Pharma.This in-depth workshop provides CRO BD Execs with the strategies necessary to approach, interact and work effectively with your current and prospective biopharma clients. And </atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/8DfNP5qbHy8/as-sponsors-increasingly-look-to-cros.html</link><author>noreply@blogger.com (Melissa)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/8DfNP5qbHy8" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/05/as-sponsors-increasingly-look-to-cros.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-4509938175062966082</guid><pubDate>Wed, 27 May 2009 19:09:00 +0000</pubDate><atom:updated>2009-05-27T15:12:35.630-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Outsourcing Clinical Trials</category><category domain="http://www.blogger.com/atom/ns#">CROs</category><category domain="http://www.blogger.com/atom/ns#">partherships with CROs</category><title>Shifting Clinical Trial Environment</title><atom:summary>Earlier today, I came across this great interactive treemap in this post in outsourcing-pharma.com that presents a unique visual analysis of the globalization of clinical trials and rise in CROs in the past 20 years.  Take a couple of minutes to view this informative map.View the interactive map</atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/CVo3VvfcgNc/shifting-clinical-trial-environment.html</link><author>noreply@blogger.com (Thiago)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/CVo3VvfcgNc" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/05/shifting-clinical-trial-environment.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-8241718702829048759</guid><pubDate>Tue, 26 May 2009 14:30:00 +0000</pubDate><atom:updated>2009-05-26T10:38:10.671-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">CROs</category><category domain="http://www.blogger.com/atom/ns#">Patient recruitment</category><category domain="http://www.blogger.com/atom/ns#">Recruitment activity</category><category domain="http://www.blogger.com/atom/ns#">Pharma Live</category><category domain="http://www.blogger.com/atom/ns#">Partnerships with CROs</category><category domain="http://www.blogger.com/atom/ns#">Clinical trials patient recruitment</category><title>Centralized patient recruitment</title><atom:summary>In a recent article at Pharma Live, they take a look at the challenge when it comes to recruiting patients and keeping clinical trials running on time.  This article focuses on the three different case studies looking at the size of the study, the number of patients sourced from a central campaign, the timing of the recruitment activity, and importantly, the effect of the patient recruitment on </atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/S4K1tSOQ3Ls/centralized-patient-recruitment.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/S4K1tSOQ3Ls" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/05/centralized-patient-recruitment.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-2343517963811920785</guid><pubDate>Wed, 20 May 2009 13:00:00 +0000</pubDate><atom:updated>2009-05-20T09:00:04.829-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">global effectiveness</category><category domain="http://www.blogger.com/atom/ns#">Global healthcare</category><category domain="http://www.blogger.com/atom/ns#">specialty pharma</category><category domain="http://www.blogger.com/atom/ns#">comparator effectiveness</category><category domain="http://www.blogger.com/atom/ns#">Global Congress on Comparator Studies</category><title>Making the Business Case for Improving your Comparator Studies</title><atom:summary>The globalization of clinical trials has arrived. As you know, the increasing use of comparator studies means that you’re playing by a new set of rules. At this critical junction, you can either evolve in 2009 to stay ahead of the curve or choose to play catch-up and try to deal with the challenges as they arise.We hope you join us this July at the Global Congress on Comparator Studies in </atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/5UlAArO73qE/making-business-case-for-improving-your.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/5UlAArO73qE" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/05/making-business-case-for-improving-your.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-8554853526758214785</guid><pubDate>Tue, 19 May 2009 14:07:00 +0000</pubDate><atom:updated>2009-05-19T10:21:52.284-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Steele Executive Search</category><category domain="http://www.blogger.com/atom/ns#">recession</category><category domain="http://www.blogger.com/atom/ns#">Changing Face of CROs</category><category domain="http://www.blogger.com/atom/ns#">Massachusetts High Tech</category><category domain="http://www.blogger.com/atom/ns#">Connie Johnson Hambley</category><category domain="http://www.blogger.com/atom/ns#">Partnerships with CROs</category><title>Recession, stimulus bill open new doors for CROs</title><atom:summary>Connie Johnson Hambley, principal, Steele Executive Search recently wrote an article on Massachusetts High Tech in which she discusses how CROs can benefit from the current economy and President Obama's economic stimulus plan. Here are a few excerpts from her article that we find are particularly relevant for our readership.Legislators, practitioners and scientists are asking how to contain the </atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/_MHlSVp6RKQ/recession-stimulus-bill-open-new-doors.html</link><author>noreply@blogger.com (Melissa)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/_MHlSVp6RKQ" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/05/recession-stimulus-bill-open-new-doors.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-3346741623075470416</guid><pubDate>Fri, 15 May 2009 13:47:00 +0000</pubDate><atom:updated>2009-05-15T09:50:13.644-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Massachusetts</category><category domain="http://www.blogger.com/atom/ns#">Ontario</category><category domain="http://www.blogger.com/atom/ns#">New York</category><category domain="http://www.blogger.com/atom/ns#">Minnesota</category><category domain="http://www.blogger.com/atom/ns#">Biotech innovation</category><category domain="http://www.blogger.com/atom/ns#">Colorado</category><category domain="http://www.blogger.com/atom/ns#">Clinical Research Outsourcing</category><category domain="http://www.blogger.com/atom/ns#">Partnerships with CROs</category><category domain="http://www.blogger.com/atom/ns#">FierceBiotech</category><category domain="http://www.blogger.com/atom/ns#">Innovation</category><title>Top Five States for Biotech Innovation</title><atom:summary>Fierce Biotech recently released their annual study that shares the top five best places in the US and Canada that provide the best resources for innovative biotechs. They are: Minnesota, Massachusetts, New York, Ontario, and Colorado.Read why each state was chosen here.</atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/89y4HyU-bXI/top-five-states-for-biotech-innovation.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/89y4HyU-bXI" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/05/top-five-states-for-biotech-innovation.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-1542637279186075353.post-6093099946086641713</guid><pubDate>Thu, 14 May 2009 15:03:00 +0000</pubDate><atom:updated>2009-05-14T11:11:45.846-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">ASKA</category><category domain="http://www.blogger.com/atom/ns#">economic research</category><category domain="http://www.blogger.com/atom/ns#">CNS</category><category domain="http://www.blogger.com/atom/ns#">clinical development solutions</category><category domain="http://www.blogger.com/atom/ns#">Association of Clinical Research Organizations</category><title>ASKA Partners with International CROs</title><atom:summary>According to Clinical Trials Today, Canadian contract research organization (CRO) ASKA Research entered into strategic partnerships with two CROs that will expand ASKA’s service offerings in North America and in Australia.The first partnership, with Queensland, Australia-based Clinical Network Services (CNS), was made possible by the Economic Research Agreement between British Columbia and </atom:summary><link>http://feedproxy.google.com/~r/PartnershipsWithCros/~3/UIAwX2r28ys/aska-partners-with-international-cros.html</link><author>noreply@blogger.com (Melissa)</author><thr:total xmlns:thr="http://purl.org/syndication/thread/1.0">0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PartnershipsWithCros/~4/UIAwX2r28ys" height="1" width="1"/&gt;</description><feedburner:origLink>http://partnershipswithcros.blogspot.com/2009/05/aska-partners-with-international-cros.html</feedburner:origLink></item></channel></rss>
